Psyence Partners with iNGENū for Palliative Care Clinical Trial in Australia

VANCOUVER, British Columbia, March 21, 2023 (GLOBE NEWSWIRE) — Psyence Group Inc (CSE:PSYG | OTCQB: PSYGF), a life science biotechnology company pioneering the use of natural psilocybin in mental health and well-being, is pleased to announce that its newly incorporated wholly owned Australian subsidiary, Psyence Australia Pty Ltd, has partnered with iNGENū Pty Ltd (iNGENū) to conduct Psyence’s…


The product has been added to your cart.

Continue shopping View Cart